The group covers several important topics very quickly, with focus on pre-launch market development, testing metrics and why it matters which companies are coming to market first. One similarity: in the absence of approved medications, disease treatment rests heavily on improving healthy lifestyles, which is a challenging target no matter the disease

TOPICS: Diabetes, EchoSens, FibroScan, MRI-PDFF, NAFLD, NASH, Novo Nordisk, Testing, Hypercholesterolemia, pleiotropic effects, metabolic syndrome, statins, GLP-1s, MRE, statins, SGLT-2s, patient screening, patient subgroups

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast